Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. III. The relationship between pregnancy rate and body weight. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation
- PMID: 2107056
- DOI: 10.1016/0010-7824(90)90143-j
Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. III. The relationship between pregnancy rate and body weight. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation
Abstract
This paper investigates the relationship between pregnancy rates and body weight of 1005 women using a vaginal ring releasing 20 micrograms levonorgestrel per 24 hours. While the overall pregnancy rate at one year was 3.7%, it was found that women have an increasing risk of pregnancy with increasing body weight. For example, a woman of 40 kg has an estimated pregnancy rate of 1.7% in contrast to 9.8% for a woman of 80 kg weight.
Similar articles
-
Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. I. Contraceptive efficacy and side effects. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation.Contraception. 1990 Feb;41(2):105-24. doi: 10.1016/0010-7824(90)90141-h. Contraception. 1990. PMID: 2107054 Clinical Trial.
-
Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. II. Expulsions and removals. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation.Contraception. 1990 Feb;41(2):125-41. doi: 10.1016/0010-7824(90)90142-i. Contraception. 1990. PMID: 2107055 Clinical Trial.
-
Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. IV. Bleeding patterns. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation.Contraception. 1990 Feb;41(2):151-67. doi: 10.1016/0010-7824(90)90144-k. Contraception. 1990. PMID: 2107057 Clinical Trial.
-
Norplant: subdermal implant system for long-term contraception.Am J Obstet Gynecol. 1989 May;160(5 Pt 2):1286-92. doi: 10.1016/s0002-9378(89)80014-6. Am J Obstet Gynecol. 1989. PMID: 2497646 Review.
-
Hormonal contraception: new long-acting methods.Popul Rep K. 1987 Mar-Apr;(3):K57-87. Popul Rep K. 1987. PMID: 3111901 Review.
Cited by
-
Pipeline for contraceptive development.Fertil Steril. 2016 Nov;106(6):1295-1302. doi: 10.1016/j.fertnstert.2016.07.1115. Epub 2016 Aug 11. Fertil Steril. 2016. PMID: 27523300 Free PMC article. Review.
-
Hormonal contraceptives for contraception in overweight or obese women.Cochrane Database Syst Rev. 2016 Aug 18;2016(8):CD008452. doi: 10.1002/14651858.CD008452.pub4. Cochrane Database Syst Rev. 2016. PMID: 27537097 Free PMC article.
-
Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women.PLoS One. 2018 Jun 28;13(6):e0199778. doi: 10.1371/journal.pone.0199778. eCollection 2018. PLoS One. 2018. PMID: 29953547 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical